Form 4: Toro Director Sells Shares After Option Exercise

James Calvin O'Rourke, a director at The Toro Company, exercised stock options and subsequently sold 4,951 shares of common stock for a significant profit.

Summary

• Director James Calvin O'Rourke exercised non-qualified stock options for 4,951 shares of Toro Co. common stock at an exercise price of $47.17 per share on March 10, 2026.
• Concurrently, O'Rourke sold 4,951 shares of Toro Co. common stock at a price of $99.4 per share on March 10, 2026.
• The transactions resulted in a beneficial ownership of 2,704 shares in a brokerage account and a total direct beneficial ownership of 16,252 shares of common stock following the reported transactions.
• The option vested in three equal annual installments commencing on the first anniversary of the November 1, 2016 grant date.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event for the insider due to the realized profit, but it's a routine liquidity event that doesn't necessarily signal strong positive or negative sentiment for the company's future performance.

Positives

• The director realized a substantial profit by selling shares at $99.4 after exercising options at $47.17, indicating a gain of $52.23 per share.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-planned sale and not necessarily a reaction to new negative information.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived as a lack of conviction in the company's immediate future by some investors, although this is a common liquidity event for executives.

Future Outlook

No forward-looking statements or guidance are provided.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for signals regarding management's confidence. While this sale was profitable and pre-planned, it represents a director reducing their direct equity exposure.

Comparison to Industry Standards

• StockSavvy.ai observes that exercising vested options and selling the underlying shares for liquidity or portfolio diversification is a standard practice among corporate executives and directors across various industries.
• The profit margin on the sale ($99.4 vs $47.17 exercise price) is substantial, reflecting the appreciation of Toro Co. stock since the option grant date, which is a positive indicator of long-term value creation for option holders compared to peers with less stock appreciation.

Related Party Transactions

• The filing details an insider transaction where a director of The Toro Company, James Calvin O'Rourke, exercised stock options and sold common stock.

Stakeholder Impact

• Shareholders: May interpret the sale as a director taking profits, which could be neutral or slightly negative depending on the context and the director's remaining holdings. However, the pre-planned nature mitigates immediate concerns.

Key Dates

Recommendation

The filing details a routine insider transaction where a director exercised options and sold shares for a profit under a pre-arranged plan. While the sale itself isn't a strong bullish signal, the pre-planned nature and the director's continued significant direct ownership (16,252 shares) suggest no immediate negative implications for the company's fundamentals. Investors should hold and monitor future company performance and broader market trends.

Keywords

Toro Co, TTC, insider trading, Form 4, stock option, share sale, director, beneficial ownership, 10b5-1 plan